ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $184,040 | -16.4% | 37,255 | +6.4% | 0.01% | -21.4% |
| Q4 2022 | $220,175 | -38.7% | 35,004 | +5.2% | 0.01% | -39.1% |
| Q3 2022 | $359,000 | -18.6% | 33,282 | -13.9% | 0.02% | 0.0% |
| Q2 2022 | $441,000 | +58.6% | 38,648 | +26.8% | 0.02% | +53.3% |
| Q1 2022 | $278,000 | -24.0% | 30,470 | +24.1% | 0.02% | -31.8% |
| Q4 2021 | $366,000 | -52.5% | 24,559 | -18.2% | 0.02% | -48.8% |
| Q3 2021 | $771,000 | -6.7% | 30,012 | -5.2% | 0.04% | -2.3% |
| Q2 2021 | $826,000 | +17.5% | 31,666 | +59.1% | 0.04% | +10.0% |
| Q1 2021 | $703,000 | +24.2% | 19,909 | -11.3% | 0.04% | -2.4% |
| Q4 2020 | $566,000 | -83.2% | 22,444 | -74.8% | 0.04% | -62.4% |
| Q3 2020 | $3,362,000 | +45.3% | 89,163 | +65.0% | 0.11% | +81.7% |
| Q2 2020 | $2,314,000 | +147.0% | 54,040 | +12.1% | 0.06% | +140.0% |
| Q1 2020 | $937,000 | -13.2% | 48,208 | +16.0% | 0.02% | +66.7% |
| Q4 2019 | $1,080,000 | – | 41,574 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |